Chordia Therapeutics株式会社 Stock: price and insider trades · Japan

Chordia Therapeutics株式会社 is a listed company. Its directors and officers file their transactions with EDINET (Japan FSA). Over the twelve months to 18 October 2026, 16 filings were filed, from 2 insiders.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Over the last twelve months, not one insider purchase of Chordia Therapeutics株式会社 stock was filed. Typically, a trade is published a median of 7 days after it takes place. This delay matters because a trade only becomes useful information once it is public.

With 16 filings in twelve months, the company is more active than the median of 3 filings across the 3,427 companies we follow on the same exchange.

These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.